Total Funding
10
9
Total FundingFunding Round raised
Growth Score
-2 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
410077
Endece is a privately held bio-pharmaceutical company at the forefront of new discovery and development.
- Jean Yarger: Chief Administrative Officer
- James Yarger: CEO and Co-founder
About the Company
Endece is a privately held biopharmaceutical company at the forefront of new discovery and development. Our library of proprietary compounds, invented and owned by ENDECE, was designed to stop disease by regulating specific biological pathways to stimulate a biological response for a gain of function. we focus on diseases whose treatment options
are limited or non-existent, whose causes may not be well understood and whose clinical development paths are still undefined including multiple sclerosis (MS) and Alzheimer's disease.
Women Founded
